CORRESP 1 filename1.htm

 

Pulmatrix, Inc.

36 Crosby Drive, Suite 100

Bedford, MA 01730

 

May 28, 2024

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

Washington, D.C. 20549

Attention: Jimmy McNamara

 

Re: Pulmatrix, Inc.
  Registration Statement on Form S-3
  Filed on May 17, 2024
  File No. 333-279491 (the “Registration Statement”)
  Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, Pulmatrix, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:30 p.m., Eastern Time, on May 30, 2024, or as soon thereafter as practicable.

 

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.

 

  Very truly yours,
   
  PULMATRIX, INC.
     
  By: /s/ Teofilo Raad
    Teofilo Raad
    Chief Executive Officer and President

 

cc: Rick A. Werner, Esq., Haynes and Boone, LLP